ロード中...
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
Most guidelines recommend long-term, indefinite neuroleptic (or antipsychotic) treatment for people with schizophrenia, recurrent psychosis or bipolar disorder, on the basis that these medications reduce the chance of relapse. However, neuroleptics have significant adverse effects, including sexual...
保存先:
| 出版年: | Ther Adv Psychopharmacol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338640/ https://ncbi.nlm.nih.gov/pubmed/32670542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320937910 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|